What is he best known for?
The fields of study he is best known for:
- Immune system
- Antibody
- Antigen
His main research concerns Immunology, Immune system, Cholera toxin, Adjuvant and Antigen.
In the subject of general Immunology, his work in Antibody, Germinal center, Inflammation and Immunoglobulin A is often linked to Lamina propria, thereby combining diverse domains of study.
His work is dedicated to discovering how Immune system, Nasal administration are connected with Immunogen and Viral matrix protein and other disciplines.
His Cholera toxin research is multidisciplinary, relying on both T cell, Antigen presentation, Molecular biology and Intestinal permeability.
His Adjuvant research is multidisciplinary, incorporating elements of Acquired immune system, Mechanism of action, Influenza vaccine, Epitope and Keyhole limpet hemocyanin.
Many of his studies on Antigen involve topics that are commonly interrelated, such as Microbiology.
His most cited work include:
- Recent progress in mucosal vaccine development: potential and limitations (401 citations)
- Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. (401 citations)
- Cholera toxin and cholera B subunit as oral—mucosal adjuvant and antigen vector systems (321 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Immunology, Immune system, Adjuvant, Cholera toxin and Antigen.
His Immunology study is mostly concerned with Immunity, Germinal center, Antibody, Immunization and T cell.
His research in Immune system focuses on subjects like Inflammation, which are connected to Arthritis and Gastritis.
He focuses mostly in the field of Adjuvant, narrowing it down to matters related to Virology and, in some cases, Chlamydia.
Nils Lycke combines subjects such as CD86, Adjuvanticity, Fusion protein, Keyhole limpet hemocyanin and CD80 with his study of Cholera toxin.
His research in Antigen intersects with topics in Molecular biology, Antigen presentation and Microbiology.
He most often published in these fields:
- Immunology (75.61%)
- Immune system (42.07%)
- Adjuvant (35.37%)
What were the highlights of his more recent work (between 2012-2021)?
- Immunology (75.61%)
- Immune system (42.07%)
- Antigen (32.93%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Immunology, Immune system, Antigen, Adjuvant and Antibody.
His Immunology research incorporates elements of Cholera toxin and Virology.
His study in the field of Priming and T cell is also linked to topics like CXCL13 and CD11c.
His Antigen research integrates issues from Adoptive cell transfer, FOXP3, Microbiology and Nasal administration.
His work deals with themes such as Toxin, Liposome, Immunogenicity and Vaccination, which intersect with Adjuvant.
His Antibody research includes elements of Virus, Molecular biology and Connective tissue.
Between 2012 and 2021, his most popular works were:
- The regulation of gut mucosal IgA B-cell responses: recent developments (62 citations)
- Re-utilization of germinal centers in multiple Peyer's patches results in highly synchronized, oligoclonal, and affinity-matured gut IgA responses. (59 citations)
- M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection. (42 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Antibody
- Antigen
Nils Lycke focuses on Immunology, Adjuvant, Antibody, Immunity and Cholera toxin.
His study brings together the fields of Virology and Immunology.
In his research on the topic of Adjuvant, Chlamydia is strongly related with Vaccination.
His work in Immunity covers topics such as Antigen which are related to areas like Nasal administration, Liposome and Adoptive cell transfer.
His Cholera toxin research is multidisciplinary, incorporating perspectives in Mechanism of action, Interleukin 12, Integrin alpha M and Enterotoxin.
His Immune system study combines topics in areas such as Epitope and Cytotoxic T cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
